Nath Bio-Genes Closes Trading Window for Q2 FY27 Results

Nath Bio-Genes (India) Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from July 1, 2026, until 48 hours after the declaration of the Unaudited Financial Results for the quarter ending June 30, 2026. The specific date for the board meeting to approve these results will be communicated separately. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.